Active substances

Cabazitaxel›

L01CD04 Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Taxanes

Indicated for: prostate cancer

Cabergoline›

G02CB03 Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals | Prolactine inhibitors

Indicated for: hyperprolactinemia

Cabotegravir›

J05AJ04 Antiinfectives for systemic use | Direct acting antivirals | Integrase inhibitors

Indicated for: HIV-1 infection

Cabozantinib›

L01EX07 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Indicated for: renal cell carcinoma; hepatocellular carcinoma; thyroid cancer

Caffeine citrate›

N06BC01 Nervous system | Psychostimulants, agents used for adhd and nootropics | Xanthine derivatives

Indicated for: apnea of prematurity

Calcifediol›

A11CC06 Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues

Indicated for: vitamin D deficiency

Calcipotriol›

D05AX02 Dermatologicals | Antipsoriatics | Antipsoriatics for topical use | Other antipsoriatics for topical use

Indicated for: psoriasis

Calcipotriol + betamethasone›

D05AX52 Dermatologicals | Antipsoriatics | Antipsoriatics for topical use | Other antipsoriatics for topical use

Indicated for: psoriasis

Calcitonin›

H05BA01 Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Calcitonin preparations

Indicated for: osteoporosis; hypercalcemia

Calcitonin (salmon)›

H05BA01 Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Calcitonin preparations

Indicated for: osteoporosis; hypercalcemia

Calcitriol›

A11CC04 Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues

Indicated for: vitamin D deficiency; calcium metabolism disorders

Calcium acetate + magnesium subcarbonate›

V03AE04 Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Indicated for: hyperphosphatemia

Calcium and magnesium glutamolactate›

A12AXN1 Alimentary tract and metabolism | Calcium | Calcium, combinations with vitamin d and/or other drugs

Indicated for: mineral deficiency; mineral supplementation

Calcium carbonate›

A12AA04 Alimentary tract and metabolism | Calcium

Indicated for: calcium deficiency; osteoporosis

Calcium carbonate + cholecalciferol›

A12AXN1 Alimentary tract and metabolism | Calcium | Calcium, combinations with vitamin d and/or other drugs

Indicated for: calcium deficiency; osteoporosis

Calcium carbonate + magnesium carbonate›

A02AD01 Alimentary tract and metabolism | Antacids | Combinations and complexes of aluminium, calcium and magnesium compounds

Indicated for: gastroesophageal reflux; acid dyspepsia

Calcium chloride›

B05XA07 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions

Indicated for: calcium deficiency; osteoporosis

Calcium dobesilate›

C05BX01 Cardiovascular system | Antivaricose therapy | Other sclerosing agents

Indicated for: chronic venous disease; capillary fragility

Calcium dobesylate + lidocaine›

C05AD01 Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Local anesthetics

Indicated for: haemorrhoids; anorectal pain and itching

Calcium dobesylate + lidocaine + dexamethasone›

C05AA09 Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Corticosteroids

Indicated for: haemorrhoids; anorectal inflammation, pain and itching

Calcium folate›

V03AF03 Various | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment

Indicated for: reduction of antifolate toxicity; folate deficiency

Calcium gluconate›

A12AA03 Alimentary tract and metabolism | Calcium

Indicated for: calcium deficiency; osteoporosis

Calcium gluconate + calcium carbonate›

A12AA20 Alimentary tract and metabolism | Calcium

Indicated for: calcium deficiency; calcium supplementation

Calcium gluconate + calcium carbonate + ascorbic acid›

A11GB01 Alimentary tract and metabolism | Ascorbic acid (vitamin C), incl. combinations | Ascorbic acid (vitamin C), combinations

Indicated for: calcium and vitamin C deficiency; mineral-vitamin supplementation

Calcium phosphate + cholecalciferol›

A11JBN1 Alimentary tract and metabolism | Other vitamin products, combinations | Vitamins with minerals

Indicated for: calcium and vitamin D deficiency; osteoporosis

Calcium polystyrene sulfonate›

V03AE01 Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Indicated for: hyperkalemia

Camizestrant›

L02BA05 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens

Indicated for: ER-positive, HER2-negative locally advanced or metastatic breast cancer with an ESR1 mutation detected without progressi

Camphor + levomenthol + eucalyptus + turpentine essential oil›

R05XN01 Respiratory system | Other cold preparations

Indicated for: cold symptoms; respiratory congestion; local muscle pain

Canagliflozin›

A10BX11 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins

Indicated for: type 2 diabetes mellitus

Canagliflozin + metformin›

A10BD16 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs

Indicated for: type 2 diabetes mellitus